Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer vs Calcium Carbonate for Heart Valve Calcification in CKD
NCT06660524Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sevelamer carbonate in heart valve calcification, sponsored by National Center for Cardiovascular Disease. Primary endpoint: Change of valve calcification score on CT scan at 1 year. Started Mar 2024; status: recruiting.
02
Drugs
sevelamer carbonate
03
Conditions
heart valve calcification
Beyond the preview
Go deeper on NCT06660524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660524.